Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity

NCT06690905 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Infections
Obesity and Obesity-related Medical Conditions

Interventions

DRUG: Piperacillin-tazobactam administered in a prolonged infusion
DRUG: Piperacillin-tazobactam administered in a standard infusion

Sponsor

CR-CSSS Champlain-Charles-Le Moyne